Impaired_JJ
binding_NN
of_IN
a_DT
DQ2_NN
and_CC
DQ8-binding_JJ
HSV_NN
VP16_NN
peptide_NN
to_TO
a_DT
DQA1_NNP
\*_NNP
0501\/DQB1_CD
\*_NNP
0302_CD
trans_JJ
class_NN
II_CD
heterodimer_NN
._.

DQalpha_NN
and_CC
DQbeta_NN
trans_JJ
heterodimeric_JJ
HLA-DQ_NN
molecules_NNS
form_VBP
in_IN
individuals_NNS
heterozygous_JJ
for_IN
the_DT
DQ2_NN
and_CC
DQ8_NN
specificities_NNS
._.

Unique_JJ
functions_NNS
and_CC
disease_NN
associations_NNS
have_VBP
been_VBN
postulated_VBN
for_IN
such_JJ
trans-dimers_NNS
,_,
which_WDT
may_MD
be_VB
different_JJ
from_IN
cis-encoded_JJ
DQ_NN
molecules_NNS
encoded_VBN
by_IN
the_DT
corresponding_JJ
haplotypes_NNS
._.

We_PRP
analyzed_VBD
the_DT
ability_NN
of_IN
the_DT
trans-dimer_NN
encoded_VBN
by_IN
HLA-DQA1_NNP
\*_NNP
0501\/DQB1_CD
\*_NNP
0302_CD
to_TO
bind_VB
a_DT
peptide_NN
antigen_NN
which_WDT
interacts_VBZ
with_IN
DQ_NN
molecules_NNS
encoded_VBN
by_IN
both_DT
parental_JJ
haplotypes_NNS
._.

Markedly_RB
impaired_JJ
binding_NN
was_VBD
observed_VBN
,_,
consistent_JJ
with_IN
both_CC
the_DT
use_NN
of_IN
different_JJ
anchor_NN
residues_NNS
and_CC
with_IN
changes_NNS
in_IN
levels_NNS
of_IN
DQ_NN
cis-dimer_JJ
availability_NN
for_IN
peptide_NN
binding_NN
interactions_NNS
._.

